The nociceptin system and hippocampal cognition in mice A pharmacological and genetic analysis

Brain Research

Volumn 1305, Issue , 2009, Pages

  Kuzmin, Alexander ^a   Madjid, Nather ^a   Johansson, Björn ^a   Terenius, Lars ^a   Ögren, Sven Ove ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Learning and memory; Mice; Nociceptin; NOP receptor; Ro 64 6198

Indexed keywords

8 (2,3,3A,4,5,6 HEXAHYDRO 1H PHENALEN 1 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; NALOXONE BENZOYLHYDRAZONE; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR ANTAGONIST; POSTSYNAPTIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; GENETIC ANALYSIS; HIPPOCAMPUS; KNOCKOUT MOUSE; LEARNING; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPATIAL MEMORY; TASK PERFORMANCE; WILD TYPE;

ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; IMIDAZOLES; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; NALOXONE; NEUROPSYCHOLOGICAL TESTS; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RANDOM ALLOCATION; RECEPTORS, OPIOID; REVERSAL LEARNING; SPIRO COMPOUNDS; TIME FACTORS;

MUS;

EID: 70649111482     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.09.075     Document Type: Article

References (56)

1. Beraki S., Kuzmin A., Tai F., and Ögren S.O. Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol. Eur. Neuropsychopharmacol. 18 7 (2008) 486-497
2. Bigoni R., Cao G., Rizzi A., Okawa H., Regoli D., Smart D., and Lambert D.G. Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors. Can. J. Physiol. Pharmacol. 80 (2002) 407-412
3. Calo G., Guerrini R., Rizzi A., Salvadori S., and Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129 (2000) 1261-1283
4. Calo G., Rizzi A., Rizzi D., Bigoni R., Guerrini R., Marzola G., Marti M., McDonald J., Morari M., Lambert D.G., Salvadori S., and Regoli D. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Br. J. Pharmacol. 136 (2002) 303-311
5. Chiou L.C., Chuang K.C., Wichmann J., and Adam G. Ro 64-6198 [(1S,3aS)-8- (2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices. J. Pharmacol. Exp. Ther. 311 2 (2004) 645-651
6. Chiou L.C., Liao Y.Y., Fan P.C., Kuo P.H., Wang C.H., Riemer C., and Prinssen E.P. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Curr. Drug Targets. 8 (2007) 117-135
7. Ciccocioppo R., Panocka I., Polidori C., Regoli D., and Massi M. Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology 141 (1999) 220-224
8. Cox B.M., Chavkin C., Christie M.J., Civelli O., Evans C., Hamon M.D., Hoellt V., Kieffer B., Kitchen I., McKnight A.T., Meunier J.C., and Portoghese P.S. Opioid receptors. In: Girdlestone D. (Ed). The IUPHAR Compendium of Receptor Characterization and Classification (2000), IUPHAR Media Ltd, London 321-333
9. Darland T., Heinricher M.M., and Grandy D.K. Orphanin GQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci. 21 (1998) 215-221
10. Devine D.P., Reinscheid R.K., Monsma Jr. F.J., Civelli O., and Akil H. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res. 727 1-2 (1996) 225-229
11. Eichenbaum H. Hippocampus: mapping or memory?. Curr. Biol. 10 (2000) R785-R787
12. Gistrak M.A., Paul D., Hahn E.F., and Pasternak G.W. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone. J. Pharmacol. Exp. Ther. 251 (1989) 469-476
13. Goeldner C., Reiss D., Wichmann J., Meziane H., Kieffer B.L., and Ouagazzal A.M. Nociceptin receptor impairs recognition memory via interaction with NMDA receptor-dependent mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in the hippocampus. J. Neurosci. 28 9 (2008) 2190-2198
14. Guerrini R., Calo G., Rizzi A., Bigoni R., Rizzi D., Regoli D., and Salvadori S. Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A. Peptides 21 (2000) 923-933
15. Henderson G., and McKnight A.T. The orphan opioid receptor and its endogenous ligand -nociceptin/orphanin FQ. Trends Pharmacol. Sci. 18 (1997) 293-300
16. Higgins G.A., Grottick A.J., Ballard T.M., Richards J.C., Messer J., Take H., Pauly-Evers M., Jenk F., Adam G., and Wichmann J. Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function. Neuropharmacology 41 (2001) 97-107
17. Higgins G.A., Kew J.N., Richards J.G., Takeshima H., Jenck F., Adam G., Wichmann J., Kemp J.A., and Grottick A.J. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory. Eur. J. Neurosci. 15 (2002) 911-922
18. Hiramatsu M., and Inoue K. Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. Eur. J. Pharmacol. 367 (1999) 151-155
19. Hiramatsu M., and Inoue K. Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory. Eur. J. Pharmacol. 395 2 (2000) 149-156
20. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29 (2006) 565-598
21. Jenck F., Wichmann J., Dautzenberg F.M., Moreau J.L., Ouagazzal A.M., Martin J.R., Lundstrom K., Cesura A.M., Poli S.M., Roever S., Kolczewski S., Adam G., and Kilpatrick G. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4938-4943
22. Koob G.F., and Le Moal M. Plasticity of reward neurocircuitry and the "dark side" of drug addiction. Nat. Neurosci. 8 (2005) 1442-1444
23. Köster A., Montkowski A., Schulz S., et al. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10444-10449
24. Kuzmin A.V., Sandin J., Terenius L., and Ögren S.O. Acquisition, expression and reinstatement of ethanol-induced conditioned place preference in mice: effects of ORL1 agonists and naloxone. J. Pharmacol. Exp. Ther. 304 (2003) 310-318
25. Kuzmin A., Sandin J., Terenius L., and Ögren S.O. Evidence in locomotion test for functional heterogenity of ORL-1 receptors. Br. J. Pharm. 141 (2004) 132-140
26. Kuzmin, A., Bazov, I., Sheedy, D., Garrick, T., Harper, C., Bakalkin, G., 2009. Expression of pronociceptin and its receptor is downregulated in the brain of human alcoholics. Brain Res, Epub ahead of print.
27. Lindholm S., Ploj K., Franck J., and Nylander I. Nociceptin/orphanin FQ tissue concentration in the rat brain. Effects of repeated ethanol administration at various post-treatment intervals. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26 2 (2002) 303-306
28. Maidment N.T., Chen Y., Tan A.M., Murphy N.P., and Leslie F.M. Rat ventral midbrain dopamine neurons express the orphanin FQ/nociceptin receptor ORL-1. NeuroReport 13 9 (2002) 1137-1140
29. Mamiya T., Noda Y., Nishi M., Takeshima H., and Nabeshima T. Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice. Brain Res. 783 (1998) 236-240
30. Mamiya T., Noda Y., Nishi M., Takeshima H., and Nabeshima T. Nociceptin system plays a role in the memory retention: involvement of naloxone benzoylhydrazone binding sites. NeuroReport 10 (1999) 1171-1175
31. Mamiya T., Yamada K., Miyamoto Y., König N., Watanabe Y., Noda Y., and Nabeshima T. Neuronal mechanism of nociceptin-induced modulation of learning and memory: involvement of N-methyl-d-aspartate receptors. Mol. Psychiatry 8 8 (2003) 752-765
32. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., Noda T., Takahashi T., Sugimoto T., Nabeshima T., and Takeshima H. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394 (1998) 577-581
33. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., and Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
34. Meunier J.C. Nociceptin/orphanin FQ, and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol. 340 (1997) 1-15
35. Morris R.G., Garrud P., Rawlins J.N., and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297 (1982) 681-683
36. Nabeshima T., Noda Y., and Mamiya T. The role of nociceptin in cognition. Brain Res. 848 (1999) 167-173
37. Nagai J., Kurokawa M., Takeshima H., Kieffer B.L., and Ueda H. Circadian-dependent learning and memory enhancement in nociceptin receptor-deficient mice with a novel KUROBOX apparatus using stress-free positive cue task. J. Pharmacol. Exp. Ther. 321 1 (2007) 195-201
38. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Akil H., and Watson Jr. S.J. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J. Comp. Neurol. 412 4 (1999) 563-605
39. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., and Watson Jr. S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406 4 (1999) 503-547
40. Nishi M., Houtani T., Noda Y., Mamiya T., Sato K., Doi T., Kuno J., Takeshima H., Nukada T., Nabeshima T., Yamashita T., Noda T., and Sugimoto T. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor. EMBO J. 16 (1997) 1858-1864
41. Noda Y., Mamiya T., Nabeshima T., Nishi M., Higashioka M., and Takeshima H. Loss of antinociception induced by naloxone benzoylhydrazone in nociceptin receptor-knockout mice. J. Biol. Chem. 273 (1998) 18047-18051
42. Noda Y., Mamiya T., Manabe T., Nishi M., Takeshima H., and Nabeshima T. Role of nociceptin systems in learning and memory. Peptides 21 (2000) 1063-1069
43. Packard M.G., and Knowlton B.J. Learning and memory functions of the basal ganglia. Annu. Rev. Neurosci. 25 (2002) 563-593
44. Redrobe J.P., Calo G., Guerrini R., Regoli D., and Quirion R. [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats. Br. J. Pharmacol. 131 (2000) 1379-1384
45. Reinscheid R.K., and Civelli O. The orphanin FQ/nociceptin knockout mouse: a behavioral model for stress responses. Neuropeptides 36 (2002) 72-76
46. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., and Civelli O. Orphanin FQ: a novel neuropeptide which is a natural ligand of an opioid-like G protein-coupled receptor. Science 270 (1995) 792-794
47. Rizzi D., Bigoni R., Rizzi A., Jenck F., Wichmann J., Guerrini R., Regoli D., and Calo G. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues. Naunyn-Schmiedebergs Arch. Pharmacol. 363 (2001) 551-555
48. Robbins T.W., Ersche K.D., and Everitt B.J. Drug addiction and the memory systems of the brain. Ann. N.Y. Acad. Sci. 1141 (2008) 1-21
49. Sandin J., Georgieva J., Schött P., Ögren S.O., and Terenius L. Nociceptin/ orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur. J. Neurosci. 9 (1997) 194-197
50. Sandin J., Ögren S.O., and Terenius L. Nociceptin/orphanin FQ modulates spatial learning via ORL-1 receptors in the dorsal hippocampus of the rat. Brain Res. 997 (2004) 222-233
51. Shoblock J.R. The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity. CNS Drug Rev. 13 (2007) 107-136
52. Sim-Selley L.J., Vogt L.J., Childers S.R., and Vogt B.A. Distribution of ORL-1 receptor binding and receptor-activated G-proteins in rat forebrain and their experimental localization in anterior cingulated cortex. Neuropharmacology 45 (2003) 220-230
53. Walker J.R., Terenius L., and Koob G.F. Conditioned opioid withdrawal decreases nociceptin/orphanin FQ levels in the frontal cortex and olfactory tubercle. Neuropsychopharmacology 27 (2002) 203-211
54. Wichmann J., Adam G., Rover S., Hennig M., Scalone M., Cesura A.M., Dautzenberg F.M., and Jenck F. Synthesis of (1S,3aS)-8-(2,3,3a,4,5, 6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4. 5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties. Eur. J. Med. Chem. 35 (2000) 839-851
55. Yu T.P., and Xie C.W. Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms. J. Neurophysiol. 80 (1998) 1277-1284
56. Yu T.P., Fein J., Phan T., Evans C.J., and Xie C.W. Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus 7 (1997) 88-94